Menās Health Month is a time dedicated to raising awareness around preventable health conditions and encouraging men to prioritize routine care and early detection. A new, FDA-approved blood test is making colorectal cancer (CRC) screening quick and easy for eligible men in Nevada to stay up to date with their regular screenings. Guardant Health, Inc., a trusted leader in … [Read more...] about This Menās Health Month, a FDA-Approved Blood Test for Colorectal Cancer Offers Men an Easier Way to Screen in Nevada
GuardantĀ Health
Guardant Healthās Shield Blood-Based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the Shield™ by Guardant blood-based screening test is now widely accessible for physician order through the nationwide connectivity of Quest Diagnostics, equipping clinicians with access to blood-based screening innovation for colorectal cancer (CRC) through one of the largest … [Read more...] about Guardant Healthās Shield Blood-Based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics
As April Marks National Cancer Prevention and Early Detection Month, FDA-Approved Blood Test for Colorectal Cancer Screening Makes It Easier to Screen in Nevada
Innovative Testing Option Proven to Close Nevadaās Screening Gap by Making it Easier for Patients to Get Screened for Colorectal Cancer In recognition of National Cancer Prevention and Early Detection Month, a time dedicated to raising awareness about the importance of preventive screening and early detection, a new, innovative blood test for colorectal cancer is transforming … [Read more...] about As April Marks National Cancer Prevention and Early Detection Month, FDA-Approved Blood Test for Colorectal Cancer Screening Makes It Easier to Screen in Nevada